Medworxx Solutions Inc. Proposes Private Placement for up to C$2,500,020 With C$1,000,000 Lead Order from Ewing Morris & Co. Investment Partners
Summary
Each whole Warrant shall entitle the holder thereof to acquire one common share of the Company at a price of $0.40 for a period of 48 months following the closing of the Offering, subject to early expiry ("Early Expiry") at the option of the Company in the event that, at any time following the date that is twenty-four months from their issuance date, the closing price of the Companys common shares on any nationally recognized stock exchange is greater than $0.85 for a period of twenty trading days in any consecutive two-month period. Our participation in the offering is consistent with our ongoing interest in acquiring fractional ownership of companies that have high customer retention rates, recurring high margin revenue and are run by managers that think like owners," said Darcy Morris, Co-President of Ewing Morris. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Founded in 2004, Medworxx Inc. is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of the Companys current and potential customers, foreign currency exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.